For CEOs of medical device companies, vascular surgeons, hospital procurement directors, and investors in cardiovascular technologies, the treatment of peripheral artery disease (PAD) represents a significant and growing clinical and market opportunity. The iliac arteries, major vessels supplying blood to the pelvis and lower limbs, are a common site for atherosclerosis, leading to debilitating symptoms like leg pain, cramping, and in severe cases, critical limb ischemia. Traditional open surgical bypass, while effective, is invasive and carries significant risks. This has driven a paradigm shift towards minimally invasive endovascular treatments, with the iliac stent emerging as a cornerstone technology. This small, expandable wire mesh tube is designed to be placed within a narrowed or blocked iliac artery, restoring blood flow and providing dramatic improvements in patient quality of life. Global Leading Market Research Publisher QYResearch announces the release of its latest report, ”Iliac Stent – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″ , offering a comprehensive market analysis of this essential and steadily growing segment of the vascular intervention market.
[Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)]
(https://www.qyresearch.com/reports/5767866/iliac-stent)
Market Analysis: Steady Growth Driven by Favorable Demographics and Technology
According to QYResearch’s latest market analysis, the global market for Iliac Stents was estimated to be worth US$ 1,275 million in 2025. Looking ahead, the industry outlook is decidedly positive, with the market projected to reach US$ 1,845 million by 2032, registering a steady Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period from 2026 to 2032. This consistent growth is underpinned by powerful, long-term drivers: an aging global population, the rising prevalence of peripheral artery disease and associated risk factors like diabetes and obesity, and continuous technological advancements that are making stents more effective, durable, and easier to deploy.
Product Definition: Restoring Lifelines to the Lower Extremities
An iliac stent is a small, tubular mesh device, typically made of metal (such as nitinol or stainless steel) or a bioresorbable polymer, that is implanted into a diseased iliac artery to restore and maintain patency. The procedure, known as iliac artery stenting, is performed percutaneously (through the skin), usually via a small puncture in the femoral artery in the groin.
The core function of the stent is to act as a mechanical scaffold, holding the artery open after it has been widened by angioplasty (balloon dilation). This prevents the vessel from recoiling and addresses dissections (flaps) that can occur during angioplasty, ensuring long-term blood flow to the pelvic organs and lower extremities. The QYResearch report segments the market by stent type, based on their deployment mechanism:
- Self-expandable Stents: These stents are made of flexible, shape-memory materials like nitinol. They are compressed and loaded into a delivery catheter. When the catheter sheath is retracted at the target site, the stent spontaneously expands to its predetermined diameter, exerting a gentle, continuous outward force on the artery wall. Self-expandable stents are particularly well-suited for vessels that are subject to external compression or flexion, such as the external iliac artery, as their flexibility allows them to conform to vessel movement.
- Balloon-expandable Stents: These stents are typically made of stronger materials like stainless steel or cobalt-chromium. They are mounted onto an angioplasty balloon and are expanded by inflating the balloon to a specific pressure. This provides a very precise and strong radial force, making them ideal for short, heavily calcified lesions and for ostial lesions (at the origin of the artery). They are often preferred in the common iliac artery where precise placement and high radial strength are critical.
- Others: This category includes covered stents (stent-grafts, lined with fabric like PTFE) used for more complex lesions such as aneurysms or ruptures, and newer-generation drug-eluting stents that release medication to inhibit tissue regrowth (restenosis).
These stents are primarily used in Hospitals and Outpatient Facilities (such as ambulatory surgical centers and specialized vascular clinics), reflecting the trend towards minimally invasive procedures in outpatient settings.
Key Market Drivers and Development Trends
Several powerful, converging trends are fueling the steady growth of the iliac stent market.
- Aging Population and Rising Disease Prevalence: The single most powerful driver is the global demographic shift towards an older population. The incidence of atherosclerosis and peripheral artery disease increases dramatically with age. Coupled with the global epidemics of diabetes, obesity, and hypertension—all major risk factors for PAD—this creates a large and growing patient population requiring intervention. Early diagnosis and treatment of PAD are also improving, further expanding the addressable market.
- The Paradigm Shift to Minimally Invasive Procedures: Both physicians and patients increasingly prefer endovascular treatment over open surgical bypass. Iliac stenting offers numerous advantages: it is performed through a small puncture, requires only local anesthesia, results in shorter hospital stays (often outpatient), has lower complication rates, and enables faster recovery and return to normal activities. This strong clinical and patient preference is a fundamental driver of market growth.
- Continuous Technological Advancements: The market is characterized by relentless innovation aimed at improving stent performance and expanding treatable lesions. Key development trends include:
- Improved Materials and Designs: Next-generation stents feature thinner struts for better deliverability, enhanced flexibility for tortuous anatomy, and optimized radial force for durable vessel support.
- Drug-Eluting Stents (DES): While more established in coronary and femoropopliteal arteries, DES technology is being applied to the iliac segment to reduce the risk of restenosis, potentially improving long-term patency rates for certain patient subsets.
- Covered Stents (Stent-Grafts): These devices are evolving for use in more complex lesions, such as iliac aneurysms or perforations, providing a physical barrier to exclude the diseased vessel segment.
- Bioresorbable Scaffolds: Although still in early stages for peripheral applications, research continues into stents that temporarily support the vessel and then gradually dissolve, leaving no permanent implant.
- Growing Awareness and Screening: Increased awareness of PAD among both the general public and primary care physicians is leading to earlier diagnosis. Simple screening tests like the ankle-brachial index (ABI) are becoming more common in at-risk populations, identifying patients with asymptomatic or mildly symptomatic disease who may benefit from intervention before their condition worsens.
- A Competitive Landscape with Major Global Players: The iliac stent market is served by a number of large, well-established medical device companies with deep expertise in vascular intervention. Key players listed in the report include BD, Abbott, Boston Scientific Corporation, W. L. Gore & Associates, Inc., Medtronic, Cook, Terumo Corporation, iVascular, Getinge AB, and Biotronik SE & Co KG. Competition is intense and focused on product performance (deliverability, flexibility, radial strength, patency rates), clinical evidence, physician training and support, and pricing and contracting with hospital systems.
Market Segmentation: By Type and Application
The QYResearch report provides a detailed segmentation, offering insights into technology choices and care settings.
- By Type (Stent Design): The segmentation into Self-expandable Stents and Balloon-expandable Stents reflects the distinct mechanical requirements of different anatomical locations and lesion types. Self-expandable stents dominate in more flexible, externally compressed segments like the external iliac. Balloon-expandable stents are preferred for precise, high-strength placement in the common iliac and for calcified lesions. The “Others” category, including covered and drug-eluting stents, represents a growing segment for complex cases.
- By Application (End-User Setting): The segmentation into Hospitals and Outpatient Facilities highlights the shift towards less invasive care. While Hospitals remain the primary site for complex interventions, Outpatient Facilities (ambulatory surgical centers, vascular clinics) are a rapidly growing segment, driven by the minimally invasive nature of the procedure and the push for cost-effective, convenient care.
Industry Outlook and Future Prospects
The industry outlook for the Iliac Stent market is one of sustained, steady growth. For CEOs and strategic leaders in this space, success will depend on:
- Continuous Product Innovation: Investing in R&D to develop next-generation stents with improved deliverability, durability, and clinical outcomes for increasingly complex lesions.
- Generating Robust Clinical Evidence: Conducting well-designed clinical trials to demonstrate the safety and efficacy of new devices, supporting regulatory approvals and adoption by physicians.
- Physician Training and Education: Providing comprehensive training and support to interventional radiologists, vascular surgeons, and cardiologists on optimal device selection and implantation techniques.
- Global Market Expansion: Developing tailored strategies for high-growth regional markets, navigating diverse regulatory pathways, and building strong distribution networks.
- Value-Based Healthcare Strategies: Working with hospital systems and payers to demonstrate the cost-effectiveness and improved patient outcomes associated with minimally invasive stent procedures.
For investors, this market offers exposure to a stable, non-cyclical, and essential segment of the medical device industry. Driven by powerful demographic trends, a clear clinical preference for minimally invasive treatment, and continuous technological innovation, the iliac stent market represents a compelling and resilient area for long-term investment.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
